BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Early pregnancy factor
,
Rosiglitazone
,
rs2300478
,
FOXP1
,
Angiogenesis
,
Lung cancer
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
peritoneal mast cells
Summary
General Info
Curated Studies
Most Correlated Studies
Myeloid cells treated with IL-10, lipopolysaccharide (LPS) or both
Explore Curated Studies Results
Literature
Most Relevant Literature
Parasitic infection improves survival from septic peritonitis by enhancing mast cell responses to ba…
Morphine-modulated mast cell migration and proliferation during early stages of zymosan-induced peri…
Systemic mast cell degranulation increases mortality during polymicrobial septic peritonitis in mice…
Gelatinase B/MMP-9 as an inflammatory marker enzyme in mouse zymosan peritonitis: comparison of phas…
A 4-trifluoromethyl analogue of celecoxib inhibits arthritis by suppressing innate immune cell activ…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Phase 2 Midostaurin in Aggressive Systemic Mastocytosis and Mast Cell Leukemia
Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Le…
Immune Checkpoints in Intraabdominal Ascites Fluid
The Status of Immune Checkpoints at Gastrointestinal Cancer
The Effects of Connective Tissue Manipulation and Abdominal Massage in Patients With Chronic Constip…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ